HBM Holdings Limited

SEHK:2142 Stock Report

Market Cap: HK$820.6m

HBM Holdings Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Jingsong Wang

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure7.8yrs
CEO ownership8.4%
Management average tenure1.3yrs
Board average tenure3.7yrs

Recent management updates

Recent updates

Take Care Before Jumping Onto HBM Holdings Limited (HKG:2142) Even Though It's 28% Cheaper

Apr 12
Take Care Before Jumping Onto HBM Holdings Limited (HKG:2142) Even Though It's 28% Cheaper

HBM Holdings Limited (HKG:2142) Surges 25% Yet Its Low P/S Is No Reason For Excitement

Jan 01
HBM Holdings Limited (HKG:2142) Surges 25% Yet Its Low P/S Is No Reason For Excitement

We're Not Very Worried About HBM Holdings' (HKG:2142) Cash Burn Rate

Feb 08
We're Not Very Worried About HBM Holdings' (HKG:2142) Cash Burn Rate

HBM Holdings (HKG:2142) Is In A Strong Position To Grow Its Business

May 30
HBM Holdings (HKG:2142) Is In A Strong Position To Grow Its Business

Revenue Downgrade: Here's What Analysts Forecast For HBM Holdings Limited (HKG:2142)

Apr 07
Revenue Downgrade: Here's What Analysts Forecast For HBM Holdings Limited (HKG:2142)

Here's What Analysts Are Forecasting For HBM Holdings Limited (HKG:2142) After Its Full-Year Results

Mar 31
Here's What Analysts Are Forecasting For HBM Holdings Limited (HKG:2142) After Its Full-Year Results

What Type Of Shareholders Own The Most Number of HBM Holdings Limited (HKG:2142) Shares?

Mar 10
What Type Of Shareholders Own The Most Number of HBM Holdings Limited (HKG:2142) Shares?

CEO Compensation Analysis

How has Jingsong Wang's remuneration changed compared to HBM Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

US$23m

Sep 30 2023n/an/a

-US$19m

Jun 30 2023n/an/a

-US$61m

Mar 31 2023n/an/a

-US$99m

Dec 31 2022n/an/a

-US$137m

Sep 30 2022n/an/a

-US$143m

Jun 30 2022n/an/a

-US$149m

Mar 31 2022n/an/a

-US$144m

Dec 31 2021US$13mUS$13m

-US$138m

Sep 30 2021n/an/a

-US$224m

Jun 30 2021n/an/a

-US$310m

Mar 31 2021n/an/a

-US$303m

Dec 31 2020US$21mUS$654k

-US$296m

Compensation vs Market: Insufficient data to establish whether Jingsong's total compensation is reasonable compared to companies of similar size in the Hong Kong market.

Compensation vs Earnings: Jingsong's compensation has been consistent with company performance over the past year.

CEO

Jingsong Wang (58 yo)

7.8yrs

Tenure

US$13,267,000

Compensation

Dr. Jingsong Wang M.D., Ph D., serves as Chairman of Board of Directors of HBM Alpha Therapeutics, Inc. He has been Chief Executive Officer of HBM Holdings Limited and Harbour BioMed Shanghai Co., Ltd. sin...

Leadership Team

NamePositionTenureCompensationOwnership
Jingsong Wang
Founderno dataUS$13.27m8.43%
$ 69.1m
Weihao Xu
CFO, Chief Business Officer and Global Head of Business & Corporate Development2.3yrsno datano data
Yiping Rong
Chief Scientific Officer & Executive Director1.3yrsno data0.028%
$ 228.5k
Bruce Zhang
Head of Legalno datano datano data
Peter Moesta
Member of Scientific Advisory Board & Chief CMC Advisorno datano datano data
Xiaolu Tao
Chief Development Officerno datano datano data
Steve Arkinstall
Chief Scientific Advisorless than a yearno datano data
Wing Yat Lui
Company Secretaryno datano datano data

1.3yrs

Average Tenure

46yo

Average Age

Experienced Management: 2142's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Jingsong Wang
Founder7.8yrsUS$13.27m8.43%
$ 69.1m
Yiping Rong
Chief Scientific Officer & Executive Director1.9yrsno data0.028%
$ 228.5k
Peter Moesta
Member of Scientific Advisory Board & Chief CMC Advisorno datano datano data
Robert Kamen
Independent Non-Executive Director & Member of Scientific Advisory Board7.3yrsUS$50.00k0.36%
$ 2.9m
Alexander A. Zukiwski
Member of Scientific Advisory Board1.9yrsno datano data
Xiaoping Ye
Independent Non-Executive Director3.4yrsUS$50.00kno data
Jon Marc Wigginton
Member of Scientific Advisory Board3.8yrsno datano data
Robert Kramer
Member of Scientific Advisory Board7.3yrsno datano data
Ka Chi Yau
Independent Non-Executive Director2.8yrsUS$28.00kno data
Frank Grosveld
Member of Scientific Advisory Board7.3yrsno datano data
Weiwei Chen
Senior Business Adviser & Non-Executive Director3.4yrsUS$22.00kno data
Zhigang Tian
Member of Scientific Advisory Board3.7yrsno datano data

3.7yrs

Average Tenure

60.5yo

Average Age

Experienced Board: 2142's board of directors are considered experienced (3.7 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.